Perrigo Company plc (PRGO)
NYSE: PRGO · Real-Time Price · USD
15.85
+0.14 (0.89%)
Nov 6, 2026, 4:00 PM EST - Market closed
Perrigo Company Revenue
Perrigo Company had revenue of $988.60M in the quarter ending September 26, 2026, a decrease of -5.24%. This brings the company's total for the last twelve months to $4.09B, down -4.47% year-over-year. In the year 2025, Perrigo Company had annual revenue of $4.25B, down -2.75%. That makes Perrigo Company the 3,042nd largest company in the world by revenue and 864th in the United States.
Revenue (ttm)
$4.09B
Revenue Growth
-4.47%
P/S Ratio
0.54
Revenue / Employee
$504,963
Employees
8,100
Market Cap
2.20B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Perrigo Company breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.25B | -120.30M | -2.75% |
| Dec 31, 2024 | 4.37B | -282.20M | -6.06% |
| Dec 31, 2023 | 4.66B | 204.00M | 4.58% |
| Dec 31, 2022 | 4.45B | 312.90M | 7.56% |
| Dec 31, 2021 | 4.14B | 50.50M | 1.24% |
| Dec 31, 2020 | 4.09B | 218.30M | 5.64% |
| Dec 31, 2019 | 3.87B | -861.80M | -18.21% |
| Dec 31, 2018 | 4.73B | -214.50M | -4.34% |
| Dec 31, 2017 | 4.95B | -334.40M | -6.33% |
| Dec 31, 2016 | 5.28B | 2.65B | 100.62% |
| Dec 31, 2015 | 2.63B | -1.59B | -37.73% |
| Jun 27, 2015 | 4.23B | 313.00M | 8.00% |
| Jun 28, 2014 | 3.91B | 374.30M | 10.57% |
| Jun 29, 2013 | 3.54B | 366.60M | 11.55% |
| Jun 30, 2012 | 3.17B | 418.20M | 15.18% |
| Jun 25, 2011 | 2.76B | 486.85M | 21.46% |
| Jun 26, 2010 | 2.27B | 262.56M | 13.09% |
| Jun 27, 2009 | 2.01B | 275.67M | 15.94% |
| Jun 28, 2008 | 1.73B | 361.57M | 26.42% |
| Jun 30, 2007 | 1.37B | 1.53M | 0.11% |
| Jul 1, 2006 | 1.37B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bausch Health Companies | 11.11B |
| Phibro Animal Health | 1.54B |
| Prestige Consumer Healthcare | 1.17B |
| Trulieve Cannabis | 1.08B |
| ANI Pharmaceuticals | 1.04B |
| BioCryst Pharmaceuticals | 961.51M |
| Pacira BioSciences | 743.30M |
| HUTCHMED (China) | 549.12M |
PRGO News
- 3 days ago - Perrigo Company Earnings Call Transcript: Q3 2026 - Transcripts
- 3 days ago - Perrigo Company Earnings release: Q3 2026 - Filings
- 3 days ago - Perrigo Company Slides: Q3 2026 - Filings
- 3 days ago - Perrigo Company Quarterly report: Q3 2026 - Filings
- 3 days ago - Perrigo Reports Third Quarter 2026 Financial Results From Continuing Operations - PRNewsWire
- 8 days ago - Perrigo price target raised to $19 from $17 at Canaccord - TheFly
- 9 days ago - Perrigo Announces Quarterly Dividend - PRNewsWire
- 9 days ago - Perrigo to divest infant formula business to MeridianMade - TheFly